Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:18 PM
Ignite Modification Date:
2025-12-24 @ 7:18 PM
NCT ID:
NCT06579703
Eligibility Criteria:
Inclusion Criteria:
* Pediatric patients with sickle cell disease (any genotype) who present to DCMC Emergency department or outpatient hematology clinic with acute pain.
Exclusion Criteria:
* Patients receiving NSAID medication \<6 hours from presentation
* known kidney injury
* sickle nephropathy
* bleeding concerns
* allergy to NSAID medication
* chronic pain patient
* hemodynamic instability as defined by the treating provider
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Day
Maximum Age:
21 Years
Study:
NCT06579703
Study Brief:
Protocol Section:
NCT06579703